Log In
BCIQ
Print this Print this
 

Alere q HIV-1/2 Detect

  Manage Alerts
Collapse Summary General Information
Company Alere Inc.
DescriptionPoint-of-care (POC) diagnostic that uses multiplexed RT-PCR for amplification and detection of HIV-1 subgroup M/N and O and HIV-2 infection
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics: Other diagnostic technologies

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$8,400.0M

$5,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/01/2016

$8,400.0M

$5,800.0M

0

Get a free BioCentury trial today